Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.03.2023 | Case report

Elasomeran/loxoprofen

Psoriatic spondyloarthritis exacerbation and treatment failure: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ohmura S, et al. A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccine. Journal of the European Academy of Dermatology and Venereology 36: e427-e429, No. 6, Jun 2022. Available from: URL: http://doi.org/10.1111/jdv.18013 Ohmura S, et al. A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccine. Journal of the European Academy of Dermatology and Venereology 36: e427-e429, No. 6, Jun 2022. Available from: URL: http://​doi.​org/​10.​1111/​jdv.​18013
Metadaten
Titel
Elasomeran/loxoprofen
Psoriatic spondyloarthritis exacerbation and treatment failure: case report
Publikationsdatum
01.03.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-35744-6

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antineoplastics

Case report

Phenazopyridine

Case report

Tozinameran

Case report

Heparin